In PLOS Genetics, researchers from France, the US, and Germany describe a mutation in the KAT2B enzyme-coding gene that appears to broaden the clinical symptoms found in individuals carrying ADD3 mutations implicated in intellectual disability, microcephaly, cataracts, and skeletal defects.